Michael S Lipkowitz
Overview
Explore the profile of Michael S Lipkowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
55
Citations
2056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Egbuna O, Zimmerman B, Manos G, Fortier A, Chirieac M, Dakin L, et al.
N Engl J Med
. 2023 Mar;
388(11):969-979.
PMID: 36920755
Background: Persons with toxic gain-of-function variants in the gene encoding apolipoprotein L1 () are at greater risk for the development of rapidly progressive, proteinuric nephropathy. Despite the known genetic cause,...
2.
Miramontes-Gonzalez J, Hightower C, Zhang K, Kurosaki H, Schork A, Biswas N, et al.
Sci Rep
. 2020 Feb;
10(1):2996.
PMID: 32060363
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
3.
Li T, Wilcox C, Lipkowitz M, Gordon-Cappitelli J, Dragoi S
Am J Nephrol
. 2019 Oct;
50(6):411-421.
PMID: 31630148
Background: Residual kidney function (RKF) conveys a survival benefit among dialysis patients, but the mechanism remains unclear. Improved volume control, clearance of protein-bound and middle molecules, reduced inflammation and preserved...
4.
Grams M, Surapaneni A, Ballew S, Appel L, Boerwinkle E, Boulware L, et al.
J Am Soc Nephrol
. 2019 Aug;
30(10):2027-2036.
PMID: 31383730
Background: Two coding variants in the apo L1 gene () are strongly associated with kidney disease in blacks. Kidney disease itself increases the risk of cardiovascular disease, but whether these...
5.
Ku E, Hsu R, Tuot D, Bae S, Lipkowitz M, Smogorzewski M, et al.
J Am Heart Assoc
. 2019 Apr;
8(9):e011013.
PMID: 31014164
Background Obtaining 24-hour ambulatory blood pressure ( BP ) is recommended for the detection of masked or white-coat hypertension. Our objective was to determine whether the magnitude of the difference...
6.
Miramontes-Gonzalez J, Hightower C, Zhang K, Kurosaki H, Schork A, Biswas N, et al.
Sci Rep
. 2019 Mar;
9(1):5055.
PMID: 30911067
The intra-renal dopamine (DA) system is highly expressed in the proximal tubule and contributes to Na+ and blood pressure homeostasis, as well as to the development of nephropathy. In the...
7.
Luo S, Coresh J, Tin A, Rebholz C, Chen T, Hayek S, et al.
Clin J Am Soc Nephrol
. 2018 Jun;
13(7):1013-1021.
PMID: 29903900
Background And Objectives: Black Americans with and without kidney disease risk variants face high risk of ESKD. Soluble urokinase-type plasminogen activator receptor (suPAR), a circulating signaling protein and marker of...
8.
Tin A, Nadkarni G, Evans A, Winkler C, Bottinger E, Rebholz C, et al.
J Am Soc Nephrol
. 2018 May;
29(7):1939-1947.
PMID: 29777021
Metabolite levels reflect physiologic homeostasis and may serve as biomarkers of disease progression. Identifying metabolites associated with risk alleles-genetic variants associated with CKD risk commonly present in persons of African...
9.
Tabriziani H, Lipkowitz M, Vuong N
Clin Kidney J
. 2018 Feb;
11(1):130-135.
PMID: 29423212
Oxidative stress plays a key role in the pathophysiological process of uremia and its complications, particularly in cardiovascular disease. The level of oxidative stress markers is known to increase as...
10.
Chen T, Tin A, Peralta C, Appel L, Choi M, Lipkowitz M, et al.
Clin J Am Soc Nephrol
. 2017 Oct;
12(11):1771-1777.
PMID: 29051146
Background And Objectives: The natural history of kidney disease among blacks who carry the high-risk variants varies, with only a subgroup progressing to ESRD. We aimed to determine whether the...